Authors
Sylvie Picard, Joëlle Dupont, Fabienne Amiot-Chapoutot, Blandine Courbebaisse, Estelle Personeni, Emmanuelle Lecornet-Sokol, François Mougel, Clara Bouché, Françoise Giroud, Sandrine Lablanche, Sophie Borot
Published in
Journal of diabetes science and technology. Pages 19322968251380291. Oct 05, 2025. Epub Oct 05, 2025.
Abstract
Hybrid closed-loop (HCL) therapy helps reaching efficacy and safety glucose targets (ESGT+) in persons with type 1 diabetes (PwT1D). We analyzed here the glycemia risk index (GRI) in PwT1D at HCL initiation (M0) and at 12 months (M12) and determined whether M0GRI value and/or M0GRI zone (A-B-C-D-E) could identify people reaching M12ESGT+.
This was a retrospective study. Consecutive PwT1D who started HCL in a CIRDIA center were included after written consent. Glucose parameters were manually extracted from platforms at M0 and M12. ESGT+ meant reaching time in range (TIR) > 70% and glucose management indicator < 7% and time below range (TBR)<70 < 4% and TBR<54< 1%. Glycemia risk index was calculated and receiver-operating characteristic (ROC) analyses were performed to study the relation between M0GRI and M12ESGT+/M12ESGT-.
M12 data were available for 128 PwT1D. M0GRI predicted M12ESGT mostly for low and high M0GRI values. An M0GRI < 41 had a 90% specificity, a 36% sensitivity, and a 74% positive predictive value for M12ESGT+. Sensitivity increased to 80% but specificity dropped to 56% for M0GRI < 61 and M0GRI ≥ 61 had a 78% negative predictive value. All PwT1D with M0GRI 0 to 20 (zone A) reached M12ESGT+. Then, the percentage of M12ESGT+ people dropped about 25% per M0GRI zone (A-B-C-D) and to 11% for zone E.
M0GRI was significantly associated with M12ESGT status but mostly when in zones A-B or D-E. Hybrid closed-loop training should focus on PwT1D with M0GRI ≥ 41 (90% of M12ESGT- persons), but reaching M12ESGT+ is possible with M0GRI in zones C-D-E (64% of M12ESGT+ persons) and even D-E (20% of M12ESGT+ persons).
PMID:
41046343
Bibliographic data and abstract were imported from PubMed on 05 Oct 2025.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 36
- Comments 0